yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q33415893-2B805223-5168-4C5A-8FB5-8D01BCB087BC
Q33415893-2B805223-5168-4C5A-8FB5-8D01BCB087BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415893-2B805223-5168-4C5A-8FB5-8D01BCB087BC
Phase 1 study of twice-weekly ixazomib, an oral proteasome inhibitor, in relapsed/refractory multiple myeloma patients
P577
Q33415893-2B805223-5168-4C5A-8FB5-8D01BCB087BC
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33415893-2B805223-5168-4C5A-8FB5-8D01BCB087BC
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d71beeaddca8e3877b8a8e922125d00496fcc51b
P577
2014-06-11T00:00:00Z
http://www.w3.org/2001/XMLSchema#dateTime
P577
0be5969597452eb2101080b51d22c625